Here’s whether Pfizer Inc. (PFE) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 55 — healthy momentum range. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.26% over 10 days). Currently 8.8% off its 52-week high. Score: +1/7.
PFE is holding above its long-term 200-day MA ($25.86) but has slipped below the 50-day MA ($26.40), pointing to short-term weakness in an otherwise intact trend. An RSI of 54.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +5.5% compares to +22.9% for SPY (trailed the market by 17.3%).
$10,000 invested 1 year ago→ $10,552 today
vs. S&P 500 (SPY) — same period trailed market by 17.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($25.86)
✗Above 50-day MA ($26.40)
✓RSI(14) neutral zone (30–70) — currently 54.7
✓Positive return (+5.5%)
✓Within 10% of period high (−8.8%)
Period Range $26.21
$23.11$28.75
RSI (14) 54.7
0 · OversoldOverbought · 100
Key Metrics
Price$26.21
Period Return+5.5%
Period High$28.75
Period Low$23.11
Drawdown−8.8%
MA-50$26.40
MA-200$25.86
RSI (14)54.7
Avg Volume (30d)35.6M
vs. SPYtrailed by 17.3%
Return Rank#649 of 1246
Trend Signals
Price is above the 200-day moving average ($25.86)